Gert Attard
Prof Gert Attard is a prominent cancer researcher and co-leader of a groundbreaking study at the UCL Cancer Institute, where he has been instrumental in developing an AI test that predicts which men with high-risk prostate cancer will benefit from the drug abiraterone, a treatment that has the potential to halve the risk of death for those identified as likely responders.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Prof Gert Attard, of the UCL Cancer Institute, co-led the study showing how algorithms can tailor treatments for prostate cancer patients.
9